2022
Exports
$115MWorld Rnk 40 / 208
Flag Rnk 22 / 1045
2022
PRODUCT COMPLEXITY IN Vaccines, blood, antisera, toxins and cultures
1.38Rnk 75 / 1025
2022
Imports
$279MWorld Rnk 69 / 225
Flag Rnk 9 / 1169
2022
ECONOMIC COMPLEXITY of Costa Rica
0.32Rnk 51 / 133

About

Exports In 2022, Costa Rica exported $115M in Vaccines, blood, antisera, toxins and cultures, making it the 40th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 22nd most exported product in Costa Rica. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Costa Rica are: Dominican Republic ($24.2M), Cuba ($19.1M), Honduras ($18.8M), Aruba ($8.55M), and Guatemala ($8.52M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Costa Rica between 2021 and 2022 were Cuba ($2.62M), Ecuador ($531k), and United States ($496k).

Imports In 2022, Costa Rica imported $279M in Vaccines, blood, antisera, toxins and cultures, becoming the 69th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 9th most imported product in Costa Rica. Costa Rica imports Vaccines, blood, antisera, toxins and cultures primarily from: Switzerland ($126M), Germany ($27.9M), Japan ($24.4M), Ireland ($21.9M), and Belgium ($19.3M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Costa Rica between 2021 and 2022 were Switzerland ($21.3M), Japan ($14.6M), and Belgium ($12.7M).

Latest Trends

Aug 2024

Subnational Monthly Trade

View
Flow
Y-AXIS SCALE

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

The following visualization shows the latest trends on Vaccines, blood, antisera, toxins and cultures. Countries are shown based on data availability.

* Using January 2020 exchange rates when trade data is reported in local currency.

Explore Latest Trends

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2022)$115M
IMPORTS (2022)$279M
NET TRADE (2022)-$164M

In 2022, Costa Rica exported $115M in Vaccines, blood, antisera, toxins and cultures. The main destinations of Costa Rica exports on Vaccines, blood, antisera, toxins and cultures were Dominican Republic ($24.2M), Cuba ($19.1M), Honduras ($18.8M), Aruba ($8.55M), and Guatemala ($8.52M).

In 2022, Costa Rica imported $279M in Vaccines, blood, antisera, toxins and cultures, mainly from Switzerland ($126M), Germany ($27.9M), Japan ($24.4M), Ireland ($21.9M), and Belgium ($19.3M).

Explore Visualizations

Export Destinations (2022)

Import Origins (2022)

Market Growth

Flow
THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR Costa Rica WERE (2021 - 2022):
Cuba$2.62M (15.9%)
Ecuador$531k (124%)
United States$496k (118%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY Costa Rica WERE (2021 - 2022):
Panama-$26M (-97.5%)
Dominican Republic-$7.46M (-23.6%)
Guatemala-$7.14M (-45.6%)

Change in Exports by Market (2021 - 2022)

Market Concentration

View
Flow
Type
In 2022, Costa Rica's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:
In 2022, Costa Rica's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:

Explore Visualizations

Trade Value of Vaccines, blood, antisera, toxins and cultures by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALUnited States+ $5.31M
TOP IMPORT POTENTIALUnited States+ $16.5M

Vaccines, blood, antisera, toxins and cultures’s highest export potential is United States. With an export gap of $5.31M.   Vaccines, blood, antisera, toxins and cultures’s highest import potential is United States with an import gap of $16.5M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with